Gland Pharma Limited

FDA inspection history in Hyderabad, India, 2019 to 2024

3
Form 483s

Every document, by year

  • Form 483

2019: one Form 483; 2023: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Hyderabad, India.
  2. 2019The longest 483 on file: 4 observations over 4 pages at Hyderabad, India.
  3. 2023–24Two Form 483s, at Hyderabad, India.

Cited most

Across all Gland Pharma Limited observations on file

The complete Gland Pharma Limited file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2024-08-02483 Form 483$99
2023-08-26483 Form 483$99
2019-11-07483 Form 483$99

FEI number 3009864167 · most recent document Aug 2, 2024

About Gland Pharma Limited

How many FDA Form 483s has Gland Pharma Limited received?

FDA Intel has 3 Form 483s on file for Gland Pharma Limited; the most recent is dated Aug 2, 2024.

When was Gland Pharma Limited last inspected by FDA?

The most recent FDA inspection document on file for Gland Pharma Limited is a Form 483 dated Aug 2, 2024, for the site in Hyderabad, India.

What did FDA cite at Gland Pharma Limited?

The regulations cited most in the observations on file for Gland Pharma Limited are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160(b) (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.